NASDAQ:NVAX

Novavax Stock Insider Trading

Healthcare > Biotechnology

Buy NVAX

*Your capital is at risk

$10.20

-0.0100 (-0.0979%)

At Close: Jun 03, 2026

Novavax Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 89.43. In total, the insiders bought 5.36M and sold 383.02K NVAX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	89.43
● Buy	5.36M shares
● Sell	383.02K shares
83% Buy Activity Moderate Negative Correlation
Sell Signal Low Confidence Mar 03, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 89.43. Partially supported by a negative historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 03, 2026 Buy	Restricted Stock Units M-Exempt	O'hara Elaine EVP, Chief Strategy Officer	Officer	56 334 Value: $534.6K
Mar 03, 2026 Buy	Common Stock M-Exempt	Casey Mark J EVP, Chief Legal Officer	Officer	37 500 Value: $355.9K
Mar 03, 2026 Sell	Restricted Stock Units D-Return	Draghia-akli Ruxandra EVP, Research & Development	Officer	26 667 Value: $0
Mar 03, 2026 Buy	Common Stock M-Exempt	Draghia-akli Ruxandra EVP, Research & Development	Officer	26 667 Value: $253.1K
Mar 02, 2026 Buy	Non-statutory Stock Option NQ A-Award	Kelly James Patrick EVP, CFO And Treasurer	C-Suite Officer	194 000 Value: $1.96M
Mar 02, 2026 Buy	Non-Statutory Stock Option NQ A-Award	Draghia-akli Ruxandra EVP, Research & Development	Officer	139 500 Value: $1.41M
Mar 02, 2026 Buy	Non-Statutory Stock Option NQ A-Award	Casey Mark J EVP, Chief Legal Officer	Officer	152 000 Value: $1.54M
Mar 02, 2026 Buy	Non-Statutory Stock Option NQ A-Award	Jacobs John C President And CEO	CEO / President	551 500 Value: $5.58M
Mar 02, 2026 Buy	2026 Non-statutory Stock Option NQ A-Award	O'hara Elaine EVP, Chief Strategy Officer	Officer	177 500 Value: $1.79M
Mar 02, 2026 Buy	Non-Statutory Stock Opotion NQ A-Award	Draghia-akli Ruxandra EVP, Research & Development	Officer	139 500 Value: $1.27M
Mar 02, 2026 Buy	Restricted Stock Units A-Award	Draghia-akli Ruxandra EVP, Research & Development	Officer	93 000 Value: $940.2K
Mar 02, 2026 Buy	Restricted Stock Units A-Award	O'hara Elaine EVP, Chief Strategy Officer	Officer	118 000 Value: $1.19M
Mar 02, 2026 Buy	2026 Non-statutory Stock Option NQ A-Award	O'hara Elaine EVP, Chief Strategy Officer	Officer	177 500 Value: $1.61M
Mar 02, 2026 Buy	Non-Statutory Stock Option NQ A-Award	Jacobs John C President And CEO	CEO / President	551 500 Value: $5.01M
Mar 02, 2026 Buy	Restricted Stock Units A-Award	Jacobs John C President And CEO	CEO / President	367 500 Value: $3.72M
Mar 02, 2026 Buy	Non-statutory Stock Option NQ A-Award	Kelly James Patrick EVP, CFO And Treasurer	C-Suite Officer	194 000 Value: $1.76M
Mar 02, 2026 Buy	Restricted Stock Units A-Award	Kelly James Patrick EVP, CFO And Treasurer	C-Suite Officer	129 500 Value: $1.31M
Mar 02, 2026 Buy	Non-Statutory Stock Opotion NQ A-Award	Casey Mark J EVP, Chief Legal Officer	Officer	152 000 Value: $1.38M
Mar 02, 2026 Buy	Restricted Stock Units A-Award	Casey Mark J EVP, Chief Legal Officer	Officer	101 000 Value: $1.02M
Mar 01, 2026 Buy	Restricted Stock Units M-Exempt	O'hara Elaine EVP, Chief Strategy Officer	Officer	19 600 Value: $199.9K
Mar 01, 2026 Buy	Restricted Stock Units M-Exempt	O'hara Elaine EVP, Chief Strategy Officer	Officer	40 000 Value: $408.0K
Mar 01, 2026 Sell	Common Stock F-InKind	O'hara Elaine EVP, Chief Strategy Officer	Officer	5 375 Value: $54.5K
Mar 01, 2026 Buy	Common Stock M-Exempt	O'hara Elaine EVP, Chief Strategy Officer	Officer	19 600 Value: $199.9K
Mar 01, 2026 Sell	Common Stock F-InKind	O'hara Elaine EVP, Chief Strategy Officer	Officer	10 969 Value: $111.2K
Mar 01, 2026 Buy	Common Stock M-Exempt	O'hara Elaine EVP, Chief Strategy Officer	Officer	40 000 Value: $408.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT NOVAVAX INC

Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical tria...

Read Full Profile Here